FDA Points the Way to Transition EUA SARS-CoV-2 Tests to Full Approval by Glenn S. Demby | Jan 19, 2022 | Articles, Clinical Diagnostics Insider, COVID-19, Diagnostic Testing and Emerging Technologies, FDA-dtet... This content is for Paid Members only.RegisterAlready a member? Log in here
COVID-19 Testing Drives Increase in Part B Medicare Lab Spending by Glenn S. Demby | Jan 14, 2022 | Articles, COVID-19, Essential, National Lab Reporter, Reimbursement-nirHere’s a look at the key takeaways from the Dec. 30 OIG report on Medicare Part B spending on lab testing. This content is for Paid Members only.RegisterAlready a member? Log in here
Omicron Forces FDA to Temporarily Shut Down Inspections by Glenn S. Demby | Jan 12, 2022 | Articles, Enforcement-nir, Essential, National Lab Reporter... This content is for Paid Members only.RegisterAlready a member? Log in here
White House Ups Effort to Resolve Rapid, At-Home COVID-19 Test Shortages by Glenn S. Demby | Jan 11, 2022 | Articles, COVID-19, Essential, National Lab Reporter, News-nir... This content is for Paid Members only.RegisterAlready a member? Log in here
Agency Unveils Guidance for Full Approval of SARS-CoV-2 Tests by Glenn S. Demby | Jan 7, 2022 | Articles, Essential, FDA-lir, Laboratory Industry Report... This content is for Paid Members only.RegisterAlready a member? Log in here